Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Latozinemab (AL001) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Latozinemab (AL001) for Frontotemporal dementia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in ... Read More
-
Osteoarthritis Market Size, Share, and Analysis, By Type (Hip Osteoarthritis, Knee Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis, Spinal Osteoarthritis), By Drug Type (Analgesics, Corticosteroids, Viscosupplementation agents, Nonsteroidal anti-inflammatory drugs {NSAIDS}), By Diagnosis (Imagining and Joint Fluid Analysis), By Route of Administration (Parenteral Route, Oral Route, Topical Route), By Treatment (Medication, Therapy, Surgery), By Distribution Channel (Hospitals Pharmacy, E-Commerce, Retail Pharmacy, Drug Store), By Purchasing Pattern (Prescription Drugs, Over-The-Counter Drugs) and Regional Forecasts, 2022-2032
... Joint Fluid Analysis), By Route of Administration (Parenteral Route, Oral Route, Topical Route), By Treatment (Medication, Therapy, Surgery), By Distribution Channel (Hospitals Pharmacy, E-Commerce, Retail Pharmacy, Drug Store), By Purchasing Pattern (Prescription Drugs, Over-The-Counter Drugs) ... Read More
-
Hearing Loss Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Product (Devices, Drugs); By Disease Type; By End-User; By Region; Segment Forecast, 2023 - 2032
... is expected treach USD 19.99 billion by 2032, according ta new study by Polaris Market Research. The report “Hearing Loss Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Product (Devices, Drugs); By Disease ... Read More
-
Zilucoplan Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the zilucoplan for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
Tuberculosis Treatment Drugs Market By Disease Type (Active Tuberculosis, Latent Tuberculosis), By Therapy Type (First Line Therapy, Second Line Therapy), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031
... and Industry Forecast, 2021-2031 The Tuberculosis Treatment Drugs Market valued for $1,929.96 million in 2021 and is estimated to reach $3,243.90 million by 2031, exhibiting a CAGR of 5.3% from 2022 to 2031. Tuberculosis (TB) ... Read More
-
ULTOMIRIS Market Drug Insight and Market Forecast − 2032
... detailed picture of the ULTOMIRIS for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
2023 Global Forecast for Cough and cold combinations, prescription (2024-2029 Outlook)-Manufacturing & Markets Report
... 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product shipments include the total value ... Read More
-
2023 Global Forecast for Vasodilators, ace inhibitors (2024-2029 Outlook)-Manufacturing & Markets Report
... Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product shipments include the total value of all ... Read More
-
Batoclimab Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the batoclimab for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
TAVNEOS (Avacopan) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the TAVNEOS (Avacopan) for Hidradenitis Suppurativa in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in ... Read More
-
Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Zunsemetinib (ATI-450) for Hidradenitis Suppurativa in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in ... Read More
-
The U.S. Weight Loss & Diet Control Market
... Covid-19 pandemic and recession. The big story of 2022 has been the soaring demand for new obesity drugs such as Wegovy and Saxenda, with more new drugs coming soon. The market may be entering a ... Read More
-
Rozanolixizumab Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the rozanolixizumab for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
Haleon Plc in Consumer Health (World)
... a key region, Asia Pacific, and the Middle East and Africa have provided significant gains.. As Rx-to-OTC switches dry up, Haleon will continue to look for strategic investments to grow inorganically. There are opportunities to ... Read More
-
2023 Global Forecast for Other hormone preparations, including sex hormone combinations, ACTH, and anabolic agents, excl progestogen (2024-2029 Outlook)-Manufacturing & Markets Report
... statistics and forecasts on the market for over 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 ... Read More
-
2023 Global Forecast for Other cold preparations, including nasal decongestants, prescription (2024-2029 Outlook)-Manufacturing & Markets Report
... for over 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product shipments include the ... Read More
-
2023 Global Forecast for Vasodilators, antiarrythmics (2024-2029 Outlook)-Manufacturing & Markets Report
... on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product shipments include the total value of all products ... Read More
-
Sonelokimab Emerging Drug Insight and Market Forecast – 2032
... the Sonelokimab for Hidradenitis Suppurativa in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
Global Escitalopram Oxalate API Market Report, History and Forecast 2018-2029
... 2022, is projected to reach a revised size of US$ 103.36 million by 2029, growing at a CAGR of 6.93% during the forecast period 2023-2029. North American market for Escitalopram Oxalate API was valued at ... Read More
-
United Kingdom Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027
... Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027 United Kingdom pharmaceutical market is expected to register robust growth in the forecast period, 2023-2027. Innovations in the fields of oncology, autoimmune, and diabetes treatment will ... Read More
-
Global Tuberculosis (TB) Treatment Market Growth (Status and Outlook) 2023-2029
... strain, will require several drugs at once. The most common medications used to treat tuberculosis include: Isoniazid Rifampin (Rifadin, Rimactane) Ethambutol (Myambutol) Pyrazinamide LPI (LP Information)' newest research report, the “Tuberculosis (TB) Treatment Industry Forecast” ... Read More
-
Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)
... global Acute Migraine Drugs market was worth USD 8.40 billion in 2021 and is anticipated to expand at a CAGR of 7.82% between 2023 and 2028. The rising prevalence of migraine among the working population, ... Read More
-
Global Anorexiants Market Growth (Status and Outlook) 2023-2029
... “Anorexiants Industry Forecast” looks at past sales and reviews total world Anorexiants sales in 2022, providing a comprehensive analysis by region and market sector of projected Anorexiants sales for 2023 through 2029. With Anorexiants sales ... Read More
-
Global Celiac Disease Drugs Market Size study & Forecast, by Drugs (First Line of Treatment and Second Line of Treatment) and Regional Analysis, 2022-2029
... in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Celiac Disease or celiac sprue or gluten-sensitive enteropathy is a digestive problem that affects ... Read More
-
Global Paget’s disease Treatment Market Size study & Forecast, by Type (Bisphosphonates, Calcitonin Analogues (Salmon Calcitonin), Analgesics, Calcium, and Vitamin D Supplements), Route of Administration (Oral, Intravenous, and Topical), and End User (Hospitals, Clinics, and Others) and Regional Analysis, 2022-2029
... Others) and Regional Analysis, 2022-2029 Global Paget’s disease Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast ... Read More
Research Assistance
